THC Therapeutics, Inc. (THCT)

THC Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is August - July.

Total Valuation

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 22, 2026	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021	Jul 31, 2020
Market Capitalization	0	0	0	1	3	2
Market Cap Growth	200.05%	-76.42%	-88.38%	-68.03%	83.70%	-96.03%
Enterprise Value	1	1	1	2	3	2
Last Close Price	0.00	0.00	0.00	0.03	0.11	0.07

Price Ratios

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 22, 2026	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021	Jul 31, 2020
PB Ratio	-0.01	-0.01	-0.03	-0.28	-1.11	-0.86

Financial Efficiency

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 22, 2026	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021	Jul 31, 2020
Debt / Equity Ratio	-0.23	-0.23	-0.24	-0.30	-0.35	-0.29
Net Debt / Equity Ratio	-0.23	-0.23	-0.24	-0.30	-0.23	-0.27
Net Debt / EBITDA Ratio	-1.62	-1.62	-1.61	-0.55	-0.61	-0.34
Net Debt / FCF Ratio	-4.78	-4.78	-9.26	-2.26	-1.44	-0.80
Quick Ratio	0	0	0	0	0.10	0.02
Current Ratio	0	0	0	0.01	0.11	0.02
Return on Assets (ROA)	-2866.01%	-2866.01%	-280.77%	-317.71%	-207.81%	-287.10%
Return on Capital Employed (ROCE)	14.30%	14.30%	14.90%	58.00%	39.50%	79.70%

Yields

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 22, 2026	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021	Jul 31, 2020
Earnings Yield	-3359.11%	-3359.11%	-377.82%	-172.37%	-68.42%	-128.75%
FCF Yield	-758.58%	-758.58%	-83.40%	-47.54%	-14.10%	-39.19%
Buyback Yield / Dilution	-8.76%	-8.76%	1.32%	-40.51%	-42.95%	-23.73%

Data Source: S&P Global Market Intelligence Last updated: Apr 30, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 26, 2026

Data Sources Report a data error